Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Nov 5, 2021

Accession no.
0001209191-21-063228
Filed
Nov 5, 2021
Trade date
Oct 1-29, 2021
Filing delay
35 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $2.40K. It was filed 35 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2021Common StockPPurchaseAcquired+42$2.69+$112.9817,220Direct
Oct 4, 2021Common StockPPurchaseAcquired+42$2.87+$120.5417,262Direct
Oct 5, 2021Common StockPPurchaseAcquired+42$2.82+$118.4417,304Direct
Oct 6, 2021Common StockPPurchaseAcquired+42$2.76+$115.9217,346Direct
Oct 7, 2021Common StockPPurchaseAcquired+42$2.76+$115.9217,388Direct
Oct 8, 2021Common StockPPurchaseAcquired+42$2.84+$119.2817,430Direct
Oct 11, 2021Common StockPPurchaseAcquired+42$2.73+$114.6617,472Direct
Oct 12, 2021Common StockPPurchaseAcquired+42$2.71+$113.8217,514Direct
Oct 13, 2021Common StockPPurchaseAcquired+42$2.71+$113.8217,556Direct
Oct 14, 2021Common StockPPurchaseAcquired+42$2.81+$118.0217,598Direct
Oct 15, 2021Common StockPPurchaseAcquired+42$2.76+$115.9217,640Direct
Oct 18, 2021Common StockPPurchaseAcquired+42$2.75+$115.517,682Direct
Oct 19, 2021Common StockPPurchaseAcquired+42$2.76+$115.9217,724Direct
Oct 20, 2021Common StockPPurchaseAcquired+42$2.63+$110.4617,766Direct
Oct 21, 2021Common StockPPurchaseAcquired+42$2.65+$111.317,808Direct
Oct 22, 2021Common StockPPurchaseAcquired+42$2.66+$111.7217,850Direct
Oct 25, 2021Common StockPPurchaseAcquired+42$2.64+$110.8817,892Direct
Oct 26, 2021Common StockPPurchaseAcquired+42$2.64+$110.8817,934Direct
Oct 27, 2021Common StockPPurchaseAcquired+42$2.61+$109.6217,976Direct
Oct 28, 2021Common StockPPurchaseAcquired+42$2.61+$109.6218,018Direct
Oct 29, 2021Common StockPPurchaseAcquired+42$2.72+$114.2418,060Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)